Evommune, Inc.

EVMN ·Healthcare, Drug Manufacturers - General, United States

← 5Y 10Y MAX →

Returns on Capital

ROE ROI ROA

Fiscal Year	ROE	ROI	ROA
FY2024	46.3%	46.3%	-87.8%
FY2025	-33.5%	-33.5%	-30.6%